Chargement en cours...

Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care

BACKGROUND: To assess the symptomatic and cost burden among patients initiating long-acting bronchodilator (LABD) therapy and impact of adherence on healthcare resource use and costs. METHODS: This retrospective cohort study identified patients with COPD who were newly prescribed a LABD (long-acting...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Respir Res
Auteurs principaux: Punekar, Yogesh Suresh, Landis, Sarah H, Wurst, Keele, Le, Hoa
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4647637/
https://ncbi.nlm.nih.gov/pubmed/26572740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0295-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!